KALA
KALA BIO, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.54
−4.53%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.15x
- Price / sales
- —
- Price / cash flow
- -0.52x
Enterprise value
- Enterprise value
- $3.2M
- EV / sales
- —
- EV / EBITDA
- -0.36x
- EV / EBIT
- -0.15x
- Market cap
- $10.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026